Capital Fund Management S.A. Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Capital Fund Management S.A.

$37.9 Billion
Q4 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2024 Feb 13, 2025	BUY	$701.85 - $1046.91 $24.6 Million - $36.7 Million	35,100 New	35,100 $25 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $15.9 Million - $17.5 Million	17,600 New	17,600 $16.9 Million
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $6.96 Million - $8.17 Million	11,700 New	11,700 $8.17 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $8.12 Million - $9.81 Million	-14,900 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $1.43 Million - $1.87 Million	-2,900 Reduced 16.29%	14,900 $9.29 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $1.78 Million - $2.62 Million	-5,300 Reduced 22.94%	17,800 $8.69 Million
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $3.76 Million - $5.16 Million	-13,700 Reduced 37.23%	23,100 $8.67 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $25.9 Million - $30.2 Million	-94,800 Reduced 72.04%	36,800 $10.2 Million
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $37.4 Million - $51.8 Million	124,800 Added 1835.29%	131,600 $41.2 Million
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $7.37 Million - $8.7 Million	-19,800 Reduced 74.44%	6,800 $2.79 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $11.5 Million - $13.8 Million	-34,200 Reduced 56.25%	26,600 $9.94 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $26.9 Million - $31.3 Million	-76,500 Reduced 55.72%	60,800 $24.6 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $8.17 Million - $9.9 Million	28,700 Added 26.43%	137,300 $47.4 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $17.3 Million - $21.5 Million	54,700 Added 101.48%	108,600 $37.4 Million
Q4 2017 Feb 09, 2018	SELL	$358.63 - $469.95 $17.3 Million - $22.6 Million	-48,100 Reduced 47.16%	53,900 $20.3 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $44 Million - $51.4 Million	102,000	102,000 $45.6 Million

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

Vanguard Group Inc Valley Forge, PA

9.29M
Shares

$6.53 Billion
0.12% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$5.94 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

7.06M
Shares

$4.96 Billion
0.41% of portfolio
State Street Corp Boston, MA

4.83M
Shares

$3.4 Billion
0.14% of portfolio
Capital International Investors Los Angeles, CA

4.74M
Shares

$3.33 Billion
0.66% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account